Replies to post #59036 on Easton Pharmaceuticals, Inc. (EAPH)

[starkd748]

No more imminently intending to form a strategy to fill out and submit a marijuana application to Health Canada....
I guess they got a brain cramp looking at the application lmfao.




Easton and iBliss intend on launching consumer health products in liquid form to be used through vaporizers. In addition to its e-liquids and vaporizer business, Easton and iBliss are developing a strategy to submit an application to Health Canada to obtain a medical marijuana license (LP) for the country Canada and anticipate a rapid approval given iBliss’ successful revenue positive business and the marijuana experience of iBliss principles who currently possess older medical marijuana licenses. The LP MMJ license is to co-incide with the recent announcement by the federal liberal government in Canada to legalize recreational medical marijuana throughout Canada to be launched in June of 2018.

The completion of the iBliss acquisition and its sales has resulted in Easton looking to retain auditors for its intent on filing a Form 10 or S1 registration statement towards becoming a fully reporting issuer with the Securities and Exchange Commission.

Evan Karras, CEO of Easton, stated, “We are excited to have completed this strategic acquisition of iBliss and we look forward to working with the iBliss management team to increase our local distribution, expand our international sales and launch innovative consumer health products. Easton has some very exciting plans and this is expected to be the first of many to follow.”


Liesssssss eaph fake news bandits
...


'Due to the closing of its Alliance Group Agreement, Easton delayed its closing with iBliss Inc as a cash payment was required to be made prior to a final closing. The new board is now currently evaluating this transaction and acquisition and may attempt to restructure the agreement terms with iBliss Inc who is an operating seller of vaporizers and proprietary e-liquids. Easton plans to minimize any share dilution by utilizing any expected sales garnered from its Alliance operations.'